Transforming Allergy Treatment

R & D

Poster List

Standardization of Tyrosine Adsorbate Depots for use as Subcutaneous Vaccines

A. D. Bullimore and M. A. Skinner
Workshop on current problems in Allergy Vaccine Development and Manufacturing, Cuba 2009

Click here to read the abstract

Challenges in design of an appropriate genotoxicity package for allergen products

S.J Hewings and M. A. Skinner
Workshop on current problems in Allergy Vaccine Development and Manufacturing, Cuba 2009

Click here to read the abstract

Novel approaches to standardizing grass mix product

A. D. Bullimore, N.J.Swan, W.A.Alawode and M. A. Skinner
Workshop on current problems in Allergy Vaccine Development and Manufacturing, Cuba 2009

Click here to read the abstract

Poster Publication

Various authors.
XXVIII EAACI conference, Warsaw, Poland, 2009

Click here to download

Mutagenicity Testing Of Modified Allergen Tyrosine Absorbate (MATA) Monophosphoryl Lipid (MPL) and Phosphatidylserine (PS) Products.

Dixon M.J., Rose S.F., Heywood J., Skinner M.A., Lees B.G., Holdich T., Wheeler A., Berry T., Bullimore. A.D, Phillips G.J.
Allergy Therapeutics Plc., Worthing, BN14 8SA, UK. and Biomedical Materials Research Group, School of Pharmacy and Biomolecular Sciences, University of Brighton, Lewes Rd, Brighton, BN2 4GJ, U.K. International Respiratory Congress, Las Vegas December 2006

Click here to read the abstract

Determination of the Solubility Characteristics of Tyrosine Adsorbed Subcutaneous Allergy Vaccines

J.P. Salvage, A.D. Bullimore, M.A. Skinner and G.J. Phillips
School of Pharmacy & Biomolecular Sciences, University of Brighton, Brighton, UK. Allergy Therapeutics Ltd, Worthing, West Sussex, UK. British Pharmaceutical Conference Sep 2008

Click here to download

Poster Publication

Various authors.
XXVII EAACI conference, Barcelona, Spain, 2008

Click here to download

Poster presentations

Various authors.
XXVI EAACI conference, Gothenberg, Sweden, 2007

Click here to download

Poster presentations

Various authors
XXV EAACI conference, Vienna, Austria, 2006

Click here to download

Poster presentations

Various authors
XXIV EAACI conference, Munich, Germany, 2005

Click here to download

Short-term immunotherapy of adults and children using pollen allergoids adjuvanted with monophosphoryl lipid A: results from a 3-year study.

E. Urban, KJ Drachenberg
Presented at XXIII EAACI Congress, Amsterdam, 12-16 June 2004.

Click here to download

Sublingual immunotherapy adjuvanted with monophosphoryl lipid A

AW Wheeler, GT Elliott, VA Cybulski, SR Woroniecki.
Allergy Therapeutics Ltd, Worthing, UK. Corixa, Seattle, WA, USA. Presented at the XXII EACCI Congress, Paris, France 7-11 June 2003

Click here to download

Short-term immunotherapy of adults and children using pollen allergoids adjuvanted with monophosphoryl lipid A: results from a two-year PMS study

E. Urban, S. Proell, KJ Drachenberg,
Bencard Allergie GmbH, Munich, Germany Presented at the XXII EACCI Congress, Paris, France 7-11 June 2003.

Click here to download

Monophosphoryl Lipid A: In Vitro Effects on Human T Cells Proliferation and Cytokines Production

F. Puggioni, J. N. Francis, S.R. Durham
Presented at AAAAI Conference, Denver, U.S.A., 7-12 March 2003

Click here to download

Collection of Poster Presentations

Various Authors
Allergy Therapeutics Ltd. Presented at the XXI EAACI Congress, Naples Italy. 1-5 June 2002

Click here to download

Standardisation of a Tyrosine-adsorbed Glutaraldehyde Modified Ragweed Pollen Vaccine (Pollinex-R)

Standardisation of a Tyrosine-adsorbed Glutaraldehyde Modified Ragweed Pollen Vaccine (Pollinex-R)
BG Lees and SJ Hewings. Allergy Therapeutics Ltd, Worthing, UK. Presented at XX EAACI Congress, Berlin, Germany, May 2001.

Click here to download

Monophosphoryl lipid A (MPL®) has Th1-stimulating properties in allergy immunotherapy with birch pollen allergoid.

B.A. Stuck, S. Schneider-Gene, L. Klimek, D. Schafer, K. Harmann. Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Mannheim, Germany Corresponding author: Dr. Boris A. Stuck, Universitats-HNO-Klinik, Klinikum Mannheim, 68135 Mannheim, Germany
Presented at XX EAACI Congress, Berlin, Germany, May 2001.

Click here to download

Tolerance and Safety of Specific Immunotherapy (SIT) with a Standardised Tyrosine-adsorbed Pollen Allergoid Adjuvanted by Monophosphoryl Lipid A (MPL®) in Children and Adolescents

KJ Drachenberg, M Heinzkill1 and E Urban
Bencard Allergie GmbH, International Medical Dept., Munich, Germany, Bencard Allergie GmbH, Medical Information, Munich, Germany. Presented at XX EAACI Congress, Berlin, Germany, May 2001.

Click here to download

Allergoid-specific T-cell reaction as a sign of the immunological response to specific immunotherapy (SIT)

Antje Hermes, Hans-Peter Scherf, Radiger von Baehr, Volker von Baehr,
Group Practice General and Internal Medicine, LADR-Academy, Laboratory Centre Berlin, Germany. Presented at XX EAACI Congress, Berlin, Germany, May 2001.

Click here to download

Three-year Short-term Specific Immunotherapy (SIT): A Multi-centre, Double-blind Placebo-controlled Study with L-tyrosine adsorbed Pollen Allergoids

KJ Drachenberg, U Feeser, and P Pfeiffer
Bencard Allergie GmbH, Munich, Germany. XIX EAACI conference, Lisbon, Portugal 2000

Click here to download

First Year's Results of a Preseasonal Four-injection Allergy Vaccine Course Adjuvanted by Monophosphoryl Lipid A (MPL®). A Multi-centre, Double-blind, Placebo-controlled Study in Grass Pollen Allergic

KJ Drachenberg, AW Wheeler, UP Stuebner, F Horak. XVIII International Congress of Allergology and Clinical Immunology, Sydney, Australia, 2000.
Bencard Allergie GmbH, Munich, Germany, Allergy Therapeutics Ltd, Worthing, UK, University ENT-Clinic, Vienna, Austria.

Click here to download

Determination of the Optimal Diagnostic Concentration (ODC) of Allergen Extracts for Skin Prick and Intradermal Testing and the Diagnostic Unit (DU)

AW Wheeler, AE Montague and KJ Drachenberg
Allergy Therapeutics Ltd., Worthing, BN14 8SA, UK Presented at XIX EAACI Congress, Lisbon, Portugal, July 2000.

Click here to download

Advantages of L-Tyrosine as a Depot Adjuvant for Formulation of Therapeutic Allergy Vaccines

A W Wheeler and B Newland
Allergy Therapeutics Ltd., Worthing, BN14 8SA, UK Presented at XIX EAACI Congress, Lisbon, Portugal, July 2000.

Click here to download

Standardisation of Diagnostic Extracts According to the EP Monograph 'Producta Allergenica' and the European Notes for Guidance to Obtain Product Registration.

B.G. Lees and A.W.Wheeler,
Allergy Therapeutics Ltd, Dominion Way Worthing, W. Sussex BN14 8SA, UK Presented at XIX EAACI Congress, Lisbon, Portugal, July 2000.

Click here to download

Quality Control and Standardisation of Tyrosine-Adsorbed Glutaraldehyde-Modified Tree Pollen Extract (Pollinex® Trees)

A W Wheeler and B Lees
Allergy Therapeutics Ltd, Dominion Way, Worthing, West Sussex, BN14 8SA, UK. Presented at XIX EAACI Congress, Lisbon, Portugal, July 2000.

Click here to download

Sublingual Immunotherapy: A Multi-Centre, randomised, double blind, placebo-controlled study with Birch and Grass Pollen extracts.

K-J Drachenberg, P Pfeiffer and U Feeser.
Bencard Allergie GmbH, Munich, Germany Presented at BSI/BSACI 7th Congress, Harrogate, UK, December 1999.

Click here to download

Short-term specific immunotherapy: A multi-centre, randomised double-blind and placebo-controlled study with L-tyrosine adsorbed pollen allergoids

K. J. Drachenberg, A. Mitsch, P. Pfeiffer
Bencard Allergie GmbH, Munich, Germany. Presented at BSI/BSACI 7th Congress, Harrogate, UK, December 1999.

Click here to download